首页 产品目录 分子砌块 按反应类型 氨基甲酸酯合成 (3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-4-hydroxybutan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol

(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-4-hydroxybutan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol

(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-4-hydroxybutan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
50mg 95% 询价
- +
100mg 95% 询价
- +
250mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1612191-86-2

英文名称

(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-4-hydroxybutan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol

别名

(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-4-hydroxybutan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol;6α-ethyl-3α,7α-dihydroxy-24-nor-5β-cholan-23-ol;BAR 502;BAR 502, 98%, a dual FXR and GPBAR1 agonist;181945;24-Norcholane-3,7,23-triol, 6-ethyl-, (3α,5β,6α,7α)-;BAR 502;BAR-502;BAR502;GPCR19,BAR 502,G protein-coupled Bile Acid Receptor 1,BAR-502,BAR502,Autophagy,GPBAR1,NR1H4,Inhibitor,G-protein coupled receptor 19,inhibit,FXR,TGR5

标准英文名

(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-4-hydroxybutan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol

分子式

C25H44O3

分子量

392.62

精确分子量

392.33

SMILES

CC[C@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H]([C@H](C)CCO)CC[C@@H]23)[C@@]2(C)CC[C@@H](O)C[C@@H]12

标准SMILES

C[C@H](CCO)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1[C@@H](CC)[C@H]3O

用途

BAR502 is a dual FXR and GPBAR1 agonist used for the treatment of metabolic and liver disorders. It reduces body weight, improves insulin sensitivity, and increases circulating HDL levels. BAR502 ameliorates hepatic steatosis, inflammation, and fibrosis by downregulating the expression of SrbB1c, Fas, PPARγ, CD36, and CYP7A1 mRNA in the liver. It attenuates CCl4-induced liver fibrosis and promotes browning of epididymal white adipose tissue (EPWAT). In models of non-obstructive cholestasis, BAR502 alleviates liver injury without inducing pruritus. Additionally, it enhances survival rates, reduces serum alkaline phosphatase levels, and robustly modulates hepatic expression of FXR target genes—including OSTα, BSEP, SHP, and MDR1—without causing itching.

InChIKey

HYCMOIGNYNCMRH-APIYUPOTSA-N

安全信息

SureRoute逆合成路线

1.  1612191-86-2 逆合成路线 1

—
—
ACQOVI773
1612191-86-2
来源: SureRoute

2.  1612191-86-2 逆合成路线 2

—
—
ACQOVI773
1612191-86-2
来源: SureRoute

3.  1612191-86-2 逆合成路线 3

—
—
ACQOVI773
1612191-86-2
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手